Efficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1

Yusuke Okayama; Teruhito Takakuwa; Ippei Otomaru; Mirei Horiuchi; Akiko Miura; Taku Araki; Yotaro Fujitani; Ryosuke Yamamura

doi:10.1002/ccr3.4126

Clinical Case Reports (May 2021)

Efficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1

Yusuke Okayama,
Teruhito Takakuwa,
Ippei Otomaru,
Mirei Horiuchi,
Akiko Miura,
Taku Araki,
Yotaro Fujitani,
Ryosuke Yamamura

Affiliations

Yusuke Okayama: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan
Teruhito Takakuwa: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan
Ippei Otomaru: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan
Mirei Horiuchi: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan
Akiko Miura: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan
Taku Araki: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan
Yotaro Fujitani: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan
Ryosuke Yamamura: Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan

DOI: https://doi.org/10.1002/ccr3.4126
Journal volume & issue: Vol. 9, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords